Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
7.10
-0.11 (-1.53%)
At close: Dec 20, 2024, 4:00 PM
7.24
+0.14 (1.97%)
After-hours: Dec 20, 2024, 4:14 PM EST
Sensus Healthcare Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Sensus Healthcare stock have an average target of 12.5, with a low estimate of 11 and a high estimate of 14. The average target predicts an increase of 76.06% from the current stock price of 7.10.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 18, 2024.
Analyst Ratings
The average analyst rating for SRTS stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $11 | Strong Buy | Maintains | $10 → $11 | +54.93% | Nov 18, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $12 → $14 | Strong Buy | Maintains | $12 → $14 | +97.18% | Nov 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +40.85% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $8 → $10 | Strong Buy | Maintains | $8 → $10 | +40.85% | May 13, 2024 |
| Maxim Group | Maxim Group | Strong Buy Maintains $7 → $10 | Strong Buy | Maintains | $7 → $10 | +40.85% | May 10, 2024 |
Financial Forecast
Revenue This Year
40.28M
from 24.41M
Increased by 65.04%
Revenue Next Year
50.29M
from 40.28M
Increased by 24.87%
EPS This Year
0.44
from 0.03
Increased by 1,370.38%
EPS Next Year
0.65
from 0.44
Increased by 48.84%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 42.8M | 58.6M | 81.9M | |
| Avg | 40.3M | 50.3M | 67.3M | |
| Low | 37.6M | 42.1M | 54.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 75.5% | 45.4% | 62.8% | |
| Avg | 65.0% | 24.9% | 33.7% | |
| Low | 54.2% | 4.4% | 8.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 0.47 | 0.95 | 1.03 | |
| Avg | 0.44 | 0.65 | 0.93 | |
| Low | 0.39 | 0.51 | 0.82 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 1,484.0% | 115.5% | 57.6% | |
| Avg | 1,370.4% | 48.8% | 42.7% | |
| Low | 1,214.2% | 16.2% | 26.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.